An Open-Label Study to Assess the Effect of CYP3A4 Induction on the Pharmacokinetics of VELCADE (Bortezomib)
Clinical trial NCT00608907 · COMPLETED
Trial details
- NCT number
- NCT00608907
- Sponsor
- Millennium Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2007-09-01
- Primary completion
- 2010-03-01
- Enrollment
- 61
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.